Robert T. Foster - Sep 21, 2023 Form 4 Insider Report for Aurinia Pharmaceuticals Inc. (AUPH)

Role
Director
Signature
/s/ Dr. Robert T. Foster
Stock symbol
AUPH
Transactions as of
Sep 21, 2023
Transactions value $
$0
Form type
4
Date filed
9/22/2023, 04:36 PM
Previous filing
Sep 19, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AUPH Restricted Stock Units Award $0 +20.4K $0.00 20.4K Sep 21, 2023 Common Stock 20.4K Direct F1, F2
transaction AUPH Stock Option (right to buy) Award $0 +32.9K $0.00 32.9K Sep 21, 2023 Common Stock 32.9K $8.34 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of the Issuer's common stock.
F2 The RSUs will vest one year from date of grant and have no expiration date. Vested shares will be delivered on September 21, 2024
F3 The option vests in twelve equal monthly installments commencing on October 21, 2023.